Department of Epidemiology, Nara Medical University School of Medicine, Nara, Japan.
Department of General Medicine, Nara Medical University School of Medicine, Nara, Japan.
Neurourol Urodyn. 2021 Jan;40(1):112-119. doi: 10.1002/nau.24550. Epub 2020 Oct 21.
To investigate the association between B-type natriuretic peptide (BNP) and nocturia among community-dwelling males and females.
A total of 1096 participants (mean age 71.9 ± 7.1 years, 518 [47.2%] males) were included in the study. The number of nocturnal voids was recorded in a self-reported urination diary, and nocturia was defined as two or more voids per night. Daytime serum concentration of the N-terminal fragment of BNP precursor (NT-proBNP) was measured. Multivariable logistic regression analysis was performed to determine the association between NT-proBNP and nocturia.
Nocturia was observed in 23.5% of females and 37.1% of males. Higher NT-proBNP (log pg/ml) was associated with nocturia in both gender groups (females: odds ratio [OR]: 1.67, 95% confidence interval [95% CI], 1.21-2.34, p = .002; males: OR: 1.26, 95% CI, 1.01-1.59, p = .046), independent of confounding variables including night-time blood pressure, mean voided volume, and chronic kidney disease. Although the increase in prevalence of nocturia with higher NT-proBNP was equivalent in both genders, some effect of gender on the relationship between NT-proBNP and nocturia was observed (p = .037). Nocturnal urine volume was also significantly and independently associated with NT-proBNP level (females: β = 32.9 ml, 95% CI, 5.63-60.2, p = .018; males: β = 34.6 ml, 95% CI, 9.40-59.9, p = .007).
This study revealed higher serum NT-proBNP is significantly and independently associated with the prevalence of nocturia in both males and females. This is an exploratory cross-sectional study and the analyses are post hoc, so further research works are needed to clarify the causality and clinical value.
探讨社区居住的男性和女性人群中心钠素(BNP)与夜尿症之间的关系。
本研究共纳入 1096 名参与者(平均年龄 71.9±7.1 岁,518 名男性)。通过自我报告的排尿日记记录夜间排尿次数,夜尿症定义为每晚排尿两次或两次以上。测量 N 端脑利钠肽前体(NT-proBNP)的血清浓度。采用多变量 logistic 回归分析来确定 NT-proBNP 与夜尿症之间的关系。
女性夜尿症发生率为 23.5%,男性为 37.1%。在两个性别组中,较高的 NT-proBNP(log pg/ml)与夜尿症相关(女性:比值比[OR]:1.67,95%置信区间[95%CI]:1.21-2.34,p=0.002;男性:OR:1.26,95%CI:1.01-1.59,p=0.046),独立于包括夜间血压、平均排尿量和慢性肾脏病在内的混杂变量。尽管随着 NT-proBNP 升高,夜尿症的患病率增加在两性中相当,但性别对 NT-proBNP 与夜尿症之间关系的影响是存在的(p=0.037)。夜间尿量也与 NT-proBNP 水平显著独立相关(女性:β=32.9ml,95%CI:5.63-60.2,p=0.018;男性:β=34.6ml,95%CI:9.40-59.9,p=0.007)。
本研究表明,较高的血清 NT-proBNP 与男性和女性的夜尿症患病率显著相关。这是一项探索性横断面研究,分析是事后分析,因此需要进一步的研究工作来阐明因果关系和临床价值。